|
|
drug metabolic process
|
GO:0017144 |
4 |
0.970
|
Rat |
|
|
short chain fatty acid catabolic process
|
GO:0019626 |
2 |
0.811
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.790
|
|
|
|
naphthalene containing compound metabolic process
|
GO:0090420 |
1 |
0.689
|
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.601
|
Rat |
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.596
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.522
|
|
|
|
naphthalene metabolic process
|
GO:0018931 |
1 |
0.518
|
|
|
|
oxygen metabolic process
|
GO:0072592 |
4 |
0.439
|
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.421
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.371
|
|
|
|
regulation of estrogen secretion
|
GO:2000861 |
1 |
0.344
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.338
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.286
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.285
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.279
|
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
26 |
0.266
|
|
|
|
renal tubular secretion
|
GO:0097254 |
2 |
0.266
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.253
|
Mouse Rat |
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.229
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.193
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.171
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.167
|
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.163
|
|
|
|
acetylcholine catabolic process
|
GO:0006581 |
1 |
0.162
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.155
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.155
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.154
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.153
|
|
|
|
retinol metabolic process
|
GO:0042572 |
9 |
0.144
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.140
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.139
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.137
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.131
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.130
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.129
|
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.128
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.127
|
|
|
|
short chain fatty acid metabolic process
|
GO:0046459 |
6 |
0.127
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.127
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.123
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.123
|
|
|
|
pyridine containing compound metabolic process
|
GO:0072524 |
14 |
0.121
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.119
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.117
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.117
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.115
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.111
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.108
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.106
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.106
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.105
|
|
|
|
ethanol metabolic process
|
GO:0006067 |
3 |
0.104
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.104
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.104
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.102
|
|
|
|
fatty acid catabolic process
|
GO:0009062 |
25 |
0.100
|
|
|
|
acylglycerol catabolic process
|
GO:0046464 |
11 |
0.099
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.098
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.097
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.095
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.094
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.094
|
|
|
|
porphyrin containing compound metabolic process
|
GO:0006778 |
22 |
0.091
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.091
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.089
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.089
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.085
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.084
|
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.084
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.084
|
|
|
|
response to xenobiotic stimulus
|
GO:0009410 |
13 |
0.082
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.081
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.080
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.080
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.080
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.079
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.078
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.078
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.077
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.076
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.076
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.075
|
|
|
|
xenobiotic catabolic process
|
GO:0042178 |
1 |
0.075
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.075
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.072
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.072
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.069
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.069
|
|
|
|
positive regulation of estrogen secretion
|
GO:2000863 |
1 |
0.068
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.068
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.067
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.067
|
|
|
|
nadp metabolic process
|
GO:0006739 |
6 |
0.065
|
|
|
|
secondary metabolic process
|
GO:0019748 |
18 |
0.065
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.065
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.063
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.063
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.063
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.062
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.062
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.062
|
|
|
|
inorganic anion transport
|
GO:0015698 |
43 |
0.061
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.061
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.060
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.060
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.060
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.059
|
|
|
|
tetrapyrrole metabolic process
|
GO:0033013 |
22 |
0.059
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.058
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.058
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.058
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.057
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.057
|
|
|
|
retinoic acid metabolic process
|
GO:0042573 |
12 |
0.055
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.055
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.055
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.054
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.054
|
|
|
|
negative regulation of nitric oxide synthase biosynthetic process
|
GO:0051771 |
1 |
0.053
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.052
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.052
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.052
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.051
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.051
|
|
|
|
nicotinamide nucleotide metabolic process
|
GO:0046496 |
12 |
0.050
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.050
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.049
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.049
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.048
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.048
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.048
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.048
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.048
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.048
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.047
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.047
|
|
|
|
toxin metabolic process
|
GO:0009404 |
5 |
0.047
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.047
|
|
|
|
glycerolipid catabolic process
|
GO:0046503 |
16 |
0.046
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.046
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.046
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.045
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.045
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.045
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.045
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.045
|
|
|
|
urate transport
|
GO:0015747 |
1 |
0.045
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.044
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.043
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.043
|
|
|
|
heme metabolic process
|
GO:0042168 |
16 |
0.043
|
|
|
|
polyol metabolic process
|
GO:0019751 |
26 |
0.043
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.043
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.042
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.042
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.042
|
|
|
|
neurotransmitter catabolic process
|
GO:0042135 |
3 |
0.042
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.042
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.042
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.041
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.040
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.040
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.040
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.040
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.040
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.040
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.039
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.039
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.039
|
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.038
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.038
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.038
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.038
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.038
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.038
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.037
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.037
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.037
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.037
|
|
|
|
sulfate assimilation
|
GO:0000103 |
3 |
0.037
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.037
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.036
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.036
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.036
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.036
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.035
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.035
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.035
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.035
|
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
29 |
0.035
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.035
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.035
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.035
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.034
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.034
|
|
|
|
linoleic acid metabolic process
|
GO:0043651 |
6 |
0.034
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.034
|
|
|
|
estrogen secretion
|
GO:0035937 |
1 |
0.034
|
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.034
|
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
1 |
0.034
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.034
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.034
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.034
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.034
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.034
|
|
|
|
positive regulation of lipid transport
|
GO:0032370 |
22 |
0.033
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.033
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.033
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.033
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.033
|
Rat |
|
|
nephron development
|
GO:0072006 |
109 |
0.032
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.032
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.032
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.032
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.032
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.031
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.031
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.031
|
|
|
|
oxidoreduction coenzyme metabolic process
|
GO:0006733 |
16 |
0.031
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.031
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.031
|
|
|
|
formaldehyde metabolic process
|
GO:0046292 |
1 |
0.031
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.031
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.031
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.031
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.030
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.030
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.030
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.030
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.030
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.030
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.030
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.030
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.030
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.030
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.030
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.029
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.029
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.029
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.029
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.029
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.029
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.029
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.029
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.029
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.029
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.028
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.028
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.028
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.028
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.028
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.028
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.028
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.028
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.028
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.028
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.028
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.027
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.027
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.027
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.027
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.027
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.027
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.027
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.027
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.027
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.027
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.027
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.027
|
|
|
|
histamine uptake
|
GO:0051615 |
1 |
0.027
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.027
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.026
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.026
|
|
|
|
pyridine nucleotide metabolic process
|
GO:0019362 |
12 |
0.026
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.026
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.026
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.026
|
|
|
|
endocrine hormone secretion
|
GO:0060986 |
15 |
0.026
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.026
|
|
|
|
receptor biosynthetic process
|
GO:0032800 |
3 |
0.026
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.025
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.025
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.025
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.025
|
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
12 |
0.025
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.025
|
|
|
|
arachidonic acid metabolic process
|
GO:0019369 |
14 |
0.025
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.025
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.025
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.025
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.024
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.024
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.024
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.024
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.024
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.024
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.024
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.024
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.024
|
|
|
|
regulation of cholesterol storage
|
GO:0010885 |
4 |
0.024
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.023
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.023
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.023
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.023
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.023
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.023
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.022
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.022
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.022
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.022
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.022
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.022
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.022
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.022
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.022
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.022
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.022
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.022
|
|
|
|
response to water deprivation
|
GO:0009414 |
1 |
0.022
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.022
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.021
|
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.021
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.021
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.021
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.021
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.021
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.021
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.021
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.021
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.021
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.021
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.021
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.021
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.021
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.021
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.021
|
|
|
|
carnitine transmembrane transport
|
GO:1902603 |
3 |
0.020
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.020
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.020
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.020
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.020
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.020
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.020
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.020
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.020
|
|
|
|
regulation of chloride transport
|
GO:2001225 |
2 |
0.020
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.020
|
|
|
|
toxin catabolic process
|
GO:0009407 |
1 |
0.020
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.020
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.020
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.020
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.020
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.020
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.019
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.019
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.019
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.019
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.019
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.019
|
|
|
|
acetate ester metabolic process
|
GO:1900619 |
3 |
0.019
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.019
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.019
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.019
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.019
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.019
|
|
|
|
histamine transport
|
GO:0051608 |
2 |
0.019
|
|
|
|
acetate metabolic process
|
GO:0006083 |
1 |
0.019
|
|
|
|
positive regulation of lipoprotein lipase activity
|
GO:0051006 |
3 |
0.018
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.018
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.018
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.018
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.018
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.018
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.018
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.018
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.018
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.018
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.018
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.018
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.018
|
|
|
|
receptor recycling
|
GO:0001881 |
11 |
0.018
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.018
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.018
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.018
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.018
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.018
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.018
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.018
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.018
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.018
|
|
|
|
regulation of dendritic cell chemotaxis
|
GO:2000508 |
1 |
0.018
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.018
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.017
|
|
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
11 |
0.017
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.017
|
|
|
|
water transport
|
GO:0006833 |
12 |
0.017
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.017
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.017
|
|
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.017
|
|
|
|
c21 steroid hormone biosynthetic process
|
GO:0006700 |
3 |
0.017
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.017
|
|
|
|
aldehyde catabolic process
|
GO:0046185 |
4 |
0.017
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.017
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.017
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.017
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.017
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.017
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.017
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.017
|
|
|
|
metanephric glomerular capillary formation
|
GO:0072277 |
3 |
0.017
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.017
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.017
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.017
|
|
|
|
bronchiole development
|
GO:0060435 |
3 |
0.017
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.017
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.017
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.017
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.017
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.017
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.017
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.016
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.016
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.016
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.016
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.016
|
|
|
|
positive regulation of cellular ph reduction
|
GO:0032849 |
2 |
0.016
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.016
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.016
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.016
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.016
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.016
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.016
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.016
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.016
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.016
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.016
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.016
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.016
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.016
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.016
|
|
|
|
hematopoietic stem cell migration
|
GO:0035701 |
1 |
0.015
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.015
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.015
|
|
|
|
response to cadmium ion
|
GO:0046686 |
8 |
0.015
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.015
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.015
|
|
|
|
plasma lipoprotein particle organization
|
GO:0071827 |
11 |
0.015
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.015
|
|
|
|
fatty acid transport
|
GO:0015908 |
28 |
0.015
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.015
|
|
|
|
neutral lipid catabolic process
|
GO:0046461 |
11 |
0.015
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.015
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.015
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.015
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.015
|
|
|
|
detection of molecule of bacterial origin
|
GO:0032490 |
2 |
0.015
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.015
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.015
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.015
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.015
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.015
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.015
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.015
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.015
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.015
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.015
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.015
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.015
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.015
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.015
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.015
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.015
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.015
|
|
|
|
acetylcholine metabolic process
|
GO:0008291 |
3 |
0.015
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.015
|
|
|
|
dibenzo p dioxin metabolic process
|
GO:0018894 |
1 |
0.015
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.015
|
|
|
|
positive regulation of t cell receptor signaling pathway
|
GO:0050862 |
4 |
0.015
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.015
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.014
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.014
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.014
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.014
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.014
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.014
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.014
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.014
|
|
|
|
positive regulation of steroid hormone secretion
|
GO:2000833 |
2 |
0.014
|
|
|
|
regulation of vitamin d biosynthetic process
|
GO:0060556 |
1 |
0.014
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.014
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.014
|
|
